CDK9-IN-39

• Target:

  Apoptosis|||CDK

• Related Pathways:

  Cell Cycle/Checkpoint|||Apoptosis

• Bioactivity:

  CDK9-IN-39 (1-7a-B1) is an orally active inhibitor of cyclin-dependent kinase 9 (CDK9), with an IC50 value of 6.51 nM. By inhibiting the phosphorylation of RNA polymerase II at the Ser2 site, CDK9-IN-39 induces cell (apoptosis) and can be used for colorectal cancer research.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C